Subscribe to Newsletter

Content by Ruth Steer:

 Subspecialties Retina

Dropping the Needle

| Ruth Steer

Topical anti-VEGF therapy may offer AMD patients an alternative to injections.
Subspecialties Retina

Ophthalmoscopy For All

| Ruth Steer

How one team is on a mission to transform eyecare with simple, clever and low cost engineering.
Subspecialties Retina

A Serious Breach of Trust

| Ruth Steer

How did people react to the news that an unapproved stem cell therapy blinded three patients?
Subspecialties Cataract

Rupture Risk

| Ruth Steer

Mounting evidence suggests intravitreal injections increase risk of PCR during cataract surgery – why?

Subspecialties Retina

Peptide Power

| Ruth Steer

Could a small biomimetic peptide be a promising alternative to anti-VEGF treatment?
Business & Profession Business and Innovation

Business in Brief

| Ruth Steer

JNJ completes AMO purchase, new CMO for Glaukos and more…
Subspecialties Basic & Translational Research

ON Delayed Gratification

| Ruth Steer

Could a newly identified retinal ganglion cell type unlock the mystery of myopia?
Subspecialties Business and Innovation

The Bot that Busts Clots

| Ruth Steer

A world first: clinical use of a robot for retinal vein cannulation.
Business & Profession Professional Development

Hang that Shingle!

| Ruth Steer

Tips for "going solo" and setting up a successful practice.
Business & Profession Professional Development

The Ophthalmologist Power List 2017

| Ruth Steer

Who are the "rising stars" of ophthalmology?
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

October Issue of The Ophthalmologist
Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: